Тигрелор

Тигрелор (Ticagrelor) is an oral antiplatelet medication used to reduce the risk of blood clots in patients with heart conditions. It belongs to the class of P2Y12 inhibitors and is commonly prescribed after heart attacks or stent placements. This medication helps prevent strokes and other cardiovascular events.

Тигрелор (Ticagrelor) is primarily used to prevent blood clots in people with acute coronary syndromes or a history of heart attack. It works by blocking platelets from clumping together, reducing the risk of serious cardiovascular events like strokes or heart attacks. This medication is often prescribed alongside low-dose aspirin for enhanced effectiveness.

Тигрелор (Ticagrelor) helps maintain healthy blood flow by preventing platelets from sticking together too easily. Users may notice improved circulation and reduced risk of clotting-related complications. Some individuals report mild side effects like shortness of breath or bruising, which are generally temporary.

Тигрелор (Ticagrelor) should be taken exactly as prescribed, and sudden discontinuation may increase clot risk. Inform your healthcare provider about any bleeding disorders or upcoming surgeries. Avoid activities that may cause injury due to increased bleeding tendency. Regular monitoring may be required during treatment.

Тигрелор (Ticagrelor) may interact with blood thinners, NSAIDs, or certain antidepressants, increasing bleeding risk. Avoid grapefruit products, as they can affect how the medication works. Some antibiotics and antifungals may also alter its effectiveness. Always disclose all medications to your doctor before starting Ticagrelor.